Hexagon Nutrition final dividend of ₹0.30 for FY26

Board recommends FY26 final dividend

Hexagon Nutrition Limited said its Board of Directors, at a meeting held on August 12, 2026, recommended a final dividend of ₹0.30 per equity share. The equity shares have a face value of ₹1 each. The recommendation is for the financial year ended March 31, 2026. As is standard, the dividend will be paid only after shareholder approval. The decision places dividend actions and governance updates in focus at a time when investors also track the company’s financial performance and corporate developments.

Shareholder approval and AGM date

The proposed final dividend is subject to shareholder approval at the company’s 33rd Annual General Meeting. The AGM has been scheduled for September 22, 2026. Until shareholders vote on the proposal, the dividend remains a recommendation rather than a finalised payout. Companies typically communicate such timelines so investors can track eligibility dates and the sequence of approvals. Hexagon Nutrition has linked the dividend recommendation with its board meeting outcomes for FY26.

Record date set for dividend eligibility

The company fixed September 15, 2026 as the record date for determining shareholders eligible to receive the final dividend, if approved. Record dates matter because they align with settlement timelines and define the cut-off for entitlement. Investors planning to hold the stock for dividend eligibility generally track the record date closely. The company’s disclosure provides a clear schedule: record date on September 15 and AGM on September 22. Any final confirmation on payment would follow shareholder approval at the AGM.

Leadership changes: Additional Executive Director appointment

Alongside the dividend recommendation, the Board moved to strengthen the leadership team. It appointed Mr. Raghunath Sawant as Additional Executive Director with effect from August 12, 2026. The company noted that Mr. Sawant has been associated with Hexagon Nutrition since July 2022. It also disclosed that he holds a Diploma in Food Technology. Such appointments are typically positioned as continuity steps, especially when the appointee has been with the business for multiple years.

Chairman and director re-appointment proposal

The Board also recommended the re-appointment of Mr. Arun Purushottam Kelkar as Chairman and Director. Company disclosures list Mr. Kelkar as Chairman and Executive Director. The management listing also includes Vikram Arun Kelkar as Managing Director, Nikhil Arun Kelkar as Joint Managing Director, and Subhash Purushottam Kelkar as Executive Director. These corporate actions indicate that alongside financial decisions like dividends, the company is also addressing board continuity through re-appointments. Shareholders typically review these items as part of AGM business.

Recent market snapshot and corporate action context

A market data snapshot in the provided information showed Hexagon Nutrition trading at ₹66.00, with a reported move of 3.29% around August 11, 2026. The same dataset referenced “Hexagon Nutrition Ltd Corporate Actions” and listed key board meeting purposes. It showed a board meeting date of 2026-08-12 for “Quarterly Results and Final Dividend,” and 2026-06-30 for “Audited Results.” These entries help map how corporate actions and disclosures have been sequenced through the quarter. Investors often use these calendars to anticipate filings and outcomes.

FY26 financial performance referenced in disclosures

The provided information also included a summary of FY26 performance. Hexagon Nutrition Limited reported a consolidated net profit of ₹379.37 million for the financial year ended March 31, 2026, up 56% from ₹243.05 million in the previous year. In normalized terms, that is about ₹37.94 crore in FY26 versus about ₹24.31 crore in FY25. Revenue was stated at ₹3,826.28 million for FY26, or about ₹382.63 crore. The disclosures attributed the FY26 profit increase to higher revenue.

Board meeting outcomes and audit-related re-appointments

A separate disclosure referenced the board approving audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, at its June 30, 2026 meeting. The same set of outcomes mentioned re-appointment of the cost auditor for FY 2026-27. It also mentioned re-appointment of the internal auditor for FY 2026-27. These audit-related decisions are commonly part of annual governance cycles, particularly around the time audited results are approved. In the context of dividend recommendations, audited results form an important backdrop because they reflect the year’s financial position.

Other corporate developments cited: lock-up and resignations

The information included references to additional corporate events from early July 2026. One item stated that 4,628,847 equity shares of Hexagon Nutrition Limited were subject to a lock-up agreement ending on July 9, 2026. Another entry referenced board resignations effective July 6, 2026, though the names were not provided in the supplied text. These events add to the timeline of governance and share-related developments leading into the August 12 board meeting. Investors typically monitor such events for their potential to change share availability and board composition.

Key facts table

Company identifiers and registered office details

The provided dataset listed Hexagon Nutrition’s BSE code as 544785, symbol as HEXAGON, and ISIN as INE0JUI01012. It also provided a registered office address: 404 Global Chamber, Adarsh Nagar, Link Road, Andheri (W), Mumbai, Maharashtra, 400053. Contact details included cs.hnpl@hexagonnutrition.com and the website http://www.hexagonnutrition.com. Such identifiers are used by investors to cross-verify filings and corporate action updates across exchanges and disclosure platforms. They also matter when tracking announcements related to dividends, board changes, and financial results.

What investors will watch next

The immediate next checkpoint is the 33rd AGM on September 22, 2026, where shareholders will vote on the final dividend recommendation and board-related items. Ahead of that, the record date on September 15, 2026 will determine eligible shareholders if the dividend is approved. Investors will also continue tracking exchange filings for any further details on dividend payment timelines post-approval. Separately, leadership changes and re-appointments will likely remain part of the AGM agenda and governance discussion. The company’s next disclosures around quarterly results and corporate actions will provide additional clarity for the market.